Skip to main content


You are here

UM Ventures News

A Ph.D.’s Journey from the Lab to Corporate Finance to CEO

DOTmed: FDA Greenlights Clearance of GammaPod Stereotactic Radiotherapy System

The FDA has given the green light for the clearance of a noninvasive stereotactic radiotherapy system in the treatment of breast cancer.

First Stereotactic Radiation Therapy System Designed to Treat Early Stage Breast Cancer Receives FDA Clearance

The GammaPod ™ is a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer, and is paving the way to bring the system to market.